Clinical Trial Update: Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab

View source ↗

Summary

Clinical trial investigating the effects of intravitreal bevacizumab on serum cholinesterases, paraoxonase, and cardiovascular risk in patients with diabetes an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetes Mellitus
• Retinal Vein Occlusion

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Ataturk University | Conditions: Diabete Mellitus, Retina Vein Occlusion | Status: RECRUITING